CAS 88411-77-2
:(6β,11β,16α)-16,17-[Butylidenebis(oxy)]-6,11,21-trihydroxypregna-1,4-diene-3,20-dione
Description:
The chemical substance known as "(6β,11β,16α)-16,17-[Butylidenebis(oxy)]-6,11,21-trihydroxypregna-1,4-diene-3,20-dione," with the CAS number 88411-77-2, is a synthetic steroid compound. It features a complex structure characterized by multiple hydroxyl groups, which contribute to its potential biological activity. The presence of the butylidene group indicates that it may exhibit unique reactivity and stability compared to other steroids. This compound is likely to interact with biological systems, possibly influencing hormonal pathways or exhibiting anti-inflammatory properties. Its structural modifications, including the diene and ketone functionalities, suggest potential applications in pharmacology, particularly in the development of therapeutic agents. As with many steroid derivatives, the specific characteristics such as solubility, melting point, and biological activity would depend on the precise arrangement of its functional groups and overall conformation. Further research would be necessary to fully elucidate its properties and potential uses in medicine or biochemistry.
Formula:C25H34O7
InChI:InChI=1S/C25H34O7/c1-4-5-21-31-20-10-15-14-9-17(28)16-8-13(27)6-7-23(16,2)22(14)18(29)11-24(15,3)25(20,32-21)19(30)12-26/h6-8,14-15,17-18,20-22,26,28-29H,4-5,9-12H2,1-3H3/t14-,15-,17+,18-,20+,21?,22+,23-,24-,25+/m0/s1
InChI key:InChIKey=JBVVDXJXIDYDMF-GVTADUIWSA-N
SMILES:C(CO)(=O)[C@]12[C@]3(C)[C@@](C[C@]1(OC(CCC)O2)[H])([C@]4([C@]([C@@H](O)C3)([C@]5(C)C([C@H](O)C4)=CC(=O)C=C5)[H])[H])[H]
Synonyms:- (6β,11β,16α)-16,17-[Butylidenebis(oxy)]-6,11,21-trihydroxypregna-1,4-diene-3,20-dione
- 6b-Hydroxybudesonide
- Pregna-1,4-diene-3,20-dione, 16,17-[butylidenebis(oxy)]-6,11,21-trihydroxy-, (6β,11β,16α)-
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 6 products.
6β-Hydroxybudesonide ((2R,6aR,6bS,7S,8aS,8bS,11aR,12aS,12bS)-2,7-dihydroxy-8b-(2-hydroxyacetyl)-6a,8a-dimethyl-10-propyl-1,2,6a,6b,7,8,8a,8b,11a,12,12a,12b-dodecahydro-4H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-4-one)
CAS:Heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFormula:C25H34O7Color and Shape:White Off-White SolidMolecular weight:446.230456-β-Hydroxy Budesonide (Mixture of Diastereomers)
CAS:Formula:C25H34O7Color and Shape:White To Off-White SolidMolecular weight:446.546β-Hydroxy Budesonide-d8
CAS:Controlled Product<p>Applications A labelled metabolite of Budesonide (B689490), a non-halogenated glucocorticoid related to triamcinolone hexacetonide. Used as an antiinflammatory agent.<br>References Ryrfeldt., A., et a.: J. Steroid Biochem., 10, 317 (1979), Roth, G., et al.: J. Pharm. Sci., 69, 766 (1980), Edsbaecker, S., et al.: Drug Metab. Dispos., 15, 412 (1987),<br></p>Formula:C25H26D8O7Purity:~90%Color and Shape:NeatMolecular weight:454.586β-Hydroxy Budesonide
CAS:Controlled ProductFormula:C25H34O7Color and Shape:White To Light YellowMolecular weight:446.536b-Hydroxy budesonide
CAS:<p>6b-Hydroxy budesonide is a drug that is metabolized to budesonide, which is a potent glucocorticoid. The pharmacokinetic profile of 6b-hydroxy budesonide was studied in animals and humans. This drug has minimal biliary excretion and is extensively metabolized by the liver. It has been shown to have anti-inflammatory effects, with cyp3a substrates being involved in its metabolism. 6b-Hydroxy budesonide binds to the glucocorticoid receptor, leading to DNA transcription and protein synthesis inhibition. 6b-Hydroxy budesonide has been used for the treatment of cirrhosis, as it helps to reduce the severity of symptoms such as nausea and vomiting.</p>Formula:C25H34O7Purity:Min. 95%Molecular weight:446.53 g/mol





